Rational design of syn-safencin, a novel linear antimicrobial peptide derived from the circular bacteriocin safencin AS-48

The Journal of Antibiotics
Francisco R FieldsShaun W Lee

Abstract

Bacteriocins hold unprecedented promise as a largely untapped source of antibiotic alternatives in the age of multidrug resistance. Here, we describe the first approach to systematically design variants of a novel AS-48 bacteriocin homologue, which we have termed safencin AS-48, from Bacillus safensis, to gain insights into engineering improved activity of bacteriocins. A library of synthetic peptides in which systematic amino acid substitutions to vary the periodicity and abundance of polar, acidic, aliphatic, and hydrophobic residues were generated for a total of 96 novel peptide variants of a single bacteriocin candidate. Using this method, we identified nine synthetic safencin (syn-safencin) variants with broad and potent antimicrobial activities with minimal inhibitory concentrations (MIC) as low as 250 nM against E. coli, P. aeruginosa, X. axonopodis, and S. pyogenes with minimal cytotoxicity to mammalian cells. It is anticipated that the strategies we have developed will serve as general guides for tuning the specificity of a given natural bacteriocin compound for therapeutic specificity.

References

Jan 6, 1999·Biochemical and Biophysical Research Communications·C A Aurell, A O Wistrom
Jul 24, 2002·Biochemistry·Gunnar FimlandJon Nissen-Meyer
Jan 7, 2005·Journal of Peptide Science : an Official Publication of the European Peptide Society·M Angeles JiménezManuel Rico
Sep 2, 2008·FEBS Letters·Manuel Montalbán-LópezAngelo Fontana
May 13, 2009·Nucleic Acids Research·Julien MaupetitPierre Tuffery
Dec 7, 2010·Biochimie·Manuel Montalbán-LópezMercedes Maqueda
May 19, 2011·Cellular and Molecular Life Sciences : CMLS·Marina Sánchez-HidalgoMercedes Maqueda
Dec 17, 2011·Nature Reviews. Drug Discovery·Christopher D FjellGisbert Schneider
Jan 24, 2012·Food Microbiology·Natacha Caballero GómezAntonio Gálvez
Feb 10, 2012·Journal of Medicinal Chemistry·Matthew J LaMarcheQingming Zhu
Dec 27, 2012·Nature Reviews. Microbiology·Paul D CotterColin Hill
Mar 13, 2014·Scientific Reports·Concetta AvitabileAlessandra Romanelli
Dec 23, 2014·Chembiochem : a European Journal of Chemical Biology·Lars Erik UggerhøjReinhard Wimmer
Mar 31, 2015·Journal of Structural Biology·Rubén CebriánMaría José Sánchez-Barrena
Aug 11, 2015·Journal of Food Science·María José Grande BurgosRosario Lucas López
Dec 8, 2015·Frontiers in Microbiology·Des FieldR P Ross
Dec 22, 2015·Biochimica Et Biophysica Acta·Ralf MikutKai Hilpert
Feb 11, 2016·Applied Microbiology and Biotechnology·Patricia Alvarez-SieiroOscar P Kuipers

❮ Previous
Next ❯

Citations

Sep 30, 2020·International Journal of Molecular Sciences·Katrina BrowneNaresh Kumar
Jun 27, 2019·BioMed Research International·Olfa Ben Braïek, Slim Smaoui
Jun 23, 2020·ACS Pharmacology & Translational Science·Francisco R FieldsShaun Lee

❮ Previous
Next ❯

Methods Mentioned

BETA
Circular Dichroism

Software Mentioned

FOLD
PEP

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.